rs62638197

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PS3PP3_StrongPP5_Very_Strong

The NM_000843.4(GRM6):​c.137C>T​(p.Pro46Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,280,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000582705: Functional studies of the P46L variant demonstrated a transport defect with intracellular retention of the receptor (Zeitz et al., 2007" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. P46P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000094 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 0 hom. )

Consequence

GRM6
NM_000843.4 missense

Scores

10
8

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:4O:1

Conservation

PhyloP100: 7.35

Publications

7 publications found
Variant links:
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
GRM6 Gene-Disease associations (from GenCC):
  • congenital stationary night blindness 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • GRM6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000582705: Functional studies of the P46L variant demonstrated a transport defect with intracellular retention of the receptor (Zeitz et al., 2007; Beqollari et al., 2009).; SCV001401018: Experimental studies have shown that this missense change affects GRM6 function (PMID: 17405131, 19666700).
PP3
MetaRNN computational evidence supports a deleterious effect, 0.963
PP5
Variant 5-178994808-G-A is Pathogenic according to our data. Variant chr5-178994808-G-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 5844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000843.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM6
NM_000843.4
MANE Select
c.137C>Tp.Pro46Leu
missense
Exon 2 of 11NP_000834.2O15303

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM6
ENST00000517717.3
TSL:5 MANE Select
c.137C>Tp.Pro46Leu
missense
Exon 2 of 11ENSP00000430767.1O15303
GRM6
ENST00000231188.9
TSL:2
c.137C>Tp.Pro46Leu
missense
Exon 1 of 10ENSP00000231188.5O15303
GRM6
ENST00000650031.1
c.137C>Tp.Pro46Leu
missense
Exon 3 of 12ENSP00000497110.1O15303

Frequencies

GnomAD3 genomes
AF:
0.0000937
AC:
14
AN:
149464
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000730
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000164
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000835
AC:
2
AN:
23960
AF XY:
0.0000675
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000217
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000162
AC:
183
AN:
1130906
Hom.:
0
Cov.:
32
AF XY:
0.000158
AC XY:
87
AN XY:
549874
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22806
American (AMR)
AF:
0.00
AC:
0
AN:
11980
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15310
East Asian (EAS)
AF:
0.00
AC:
0
AN:
23848
South Asian (SAS)
AF:
0.00
AC:
0
AN:
39878
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
24126
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3014
European-Non Finnish (NFE)
AF:
0.000187
AC:
177
AN:
945622
Other (OTH)
AF:
0.000135
AC:
6
AN:
44322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000936
AC:
14
AN:
149572
Hom.:
0
Cov.:
33
AF XY:
0.0000959
AC XY:
7
AN XY:
72994
show subpopulations
African (AFR)
AF:
0.0000727
AC:
3
AN:
41238
American (AMR)
AF:
0.00
AC:
0
AN:
15018
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3422
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9538
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000164
AC:
11
AN:
67104
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000680

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
not provided (3)
1
-
-
Congenital stationary night blindness (1)
1
-
-
Congenital stationary night blindness 1B (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
30
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.83
D
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.59
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Uncertain
0.40
D
MutationAssessor
Uncertain
2.3
M
PhyloP100
7.3
PrimateAI
Pathogenic
0.97
D
PROVEAN
Pathogenic
-8.0
D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0030
D
Polyphen
0.95
P
Vest4
0.90
MutPred
0.86
Gain of catalytic residue at P46 (P = 0.0246)
MVP
0.86
MPC
2.3
ClinPred
0.96
D
GERP RS
3.2
PromoterAI
0.029
Neutral
Varity_R
0.52
gMVP
0.66
Mutation Taster
=10/90
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62638197; hg19: chr5-178421809; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.